Abstract
Background
The objective of the present study was to evaluate the utility of preoperative localizing studies in patients with MEN1 undergoing initial bilateral neck exploration (BNE) and parathyroidectomy for pHPT.
Methods
We performed a retrospective analysis of patients diagnosed with MEN1 who underwent initial parathyroidectomy between December 1993 and December 2010. Results of preoperative localizing studies were compared with intraoperative findings and outcome.
Results
Sixty patients with MEN1 (32 females and 28 males) underwent initial subtotal parathyroidectomy. The median age at the time of surgery was 33 years (range: 13–78 years). Fifty-three patients had one or more positive localizing study results. Neck ultrasonography, sestamibi scan, parathyroid protocol computed tomography scan, and neck and mediastinum magnetic resonance imaging were performed in 93, 91, 32, and 19% of patients, respectively. Fifty-three patients (88%) had cervical thymectomy. Twenty patients had 24 ectopic parathyroid glands; 18 glands were in the thymus (75%). Preoperative localizing studies identified 9 of 24 ectopic parathyroid glands (38%), including 4 ectopic glands outside the thymus in 4 patients (7%); 3 were detected by ultrasonography. There were no supernumerary glands identified on preoperative localizing studies.
Conclusions
In patients with MEN1, preoperative localizing studies identified a subset of ectopic glands (38%). Preoperative localizing studies may alter the operative approach in 7% of patients. Ultrasonography can detect most ectopic parathyroid glands outside thymus. This suggests that routine preoperative localizing studies to identify ectopic and supernumerary enlarged parathyroid glands is not useful in the majority of patients with MEN1 undergoing bilateral neck exploration and subtotal parathyroidectomy with cervical thymectomy.
Similar content being viewed by others
References
Skogseid B, Eriksson B, Lundqvist G et al (1991) Multiple endocrine neoplasia type 1: a 10-year prospective screening study in four kindreds. J Clin Endocrinol Metab 73:281–287
Lairmore TC, Piersall LD, DeBenedetti MK et al (2004) Clinical genetic testing and early surgical intervention in patients with multiple endocrine neoplasia type 1 (MEN 1). Ann Surg 239:637–645 discussion 645–637
Marini F, Falchetti A, Luzi E et al (2009) Multiple endocrine neoplasia type 1 (MEN1) syndrome. In: Riegert-Johnson DL, Boardman LA, Hefferon T, Roberts M (eds) Cancer syndromes. National Center for Biotechnology Information, Bethesda
Brandi ML, Marx SJ, Aurbach GD et al (1987) Familial multiple endocrine neoplasia type I: a new look at pathophysiology. Endocr Rev 8:391–405
Vasen HF, Griffioen G, Lips CJ et al (1990) Screening of families predisposed to cancer development in the Netherlands. Anticancer Res 10:555–563
Uchino S, Noguchi S, Sato M et al (2000) Screening of the Men1 gene and discovery of germ-line and somatic mutations in apparently sporadic parathyroid tumors. Cancer Res 60:5553–5557
Akerstrom G, Stalberg P (2009) Surgical management of MEN-1 and -2: state of the art. Surg Clin North Am 89:1047–1068
VanderWalde LH, Haigh PI (2006) Surgical approach to the patient with familial hyperparathyroidism. Curr Treat Options Oncol 7:326–333
Lambert LA, Shapiro SE, Lee JE et al (2005) Surgical treatment of hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Arch Surg 140:374–382
Hubbard JG, Sebag F, Maweja S et al (2002) Primary hyperparathyroidism in MEN 1—how radical should surgery be? Langenbecks Arch Surg 386:553–557
Thompson NW (1995) The surgical management of hyperparathyroidism and endocrine disease of the pancreas in the multiple endocrine neoplasia type 1 patient. J Intern Med 238:269–280
Powell AC, Alexander HR, Pingpank JF et al (2008) The utility of routine transcervical thymectomy for multiple endocrine neoplasia 1-related hyperparathyroidism. Surgery 144:878–883 discussion 883–874
Stalberg P, Carling T (2009) Familial parathyroid tumors: diagnosis and management. World J Surg 33:2234–2243. doi:10.1007/s00268-009-9924-6
Hellman P, Skogseid B, Oberg K et al (1998) Primary and reoperative parathyroid operations in hyperparathyroidism of multiple endocrine neoplasia type 1. Surgery 124:993–999
Brandi ML, Gagel RF, Angeli A et al (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86:5658–5671
Miller DL, Doppman JL, Shawker TH et al (1987) Localization of parathyroid adenomas in patients who have undergone surgery. Part I. Noninvasive imaging methods. Radiology 162:133–137
Chen CC, Skarulis MC, Fraker DL et al (1995) Technetium-99 m-sestamibi imaging before reoperation for primary hyperparathyroidism. J Nucl Med 36:2186–2191
Feingold DL, Alexander HR, Chen CC et al (2000) Ultrasound and sestamibi scan as the only preoperative imaging tests in reoperation for parathyroid adenomas. Surgery 128:1103–1109 discussion 1109–1110
Westerdahl J, Bergenfelz A (2007) Unilateral versus bilateral neck exploration for primary hyperparathyroidism: five-year follow-up of a randomized controlled trial. Ann Surg 246:976–980 discussion 980–971
Rizzoli R, Green J 3rd, Marx SJ (1985) Primary hyperparathyroidism in familial multiple endocrine neoplasia type I. Long-term follow-up of serum calcium levels after parathyroidectomy. Am J Med 78:467–474
Burgess JR, David R, Parameswaran V et al (1998) The outcome of subtotal parathyroidectomy for the treatment of hyperparathyroidism in multiple endocrine neoplasia type 1. Arch Surg 133:126–129
Kraimps JL, Duh QY, Demeure M et al (1992) Hyperparathyroidism in multiple endocrine neoplasia syndrome. Surgery 112:1080–1086 discussion 1086–1088
Prinz RA, Gamvros OI, Sellu D et al (1981) Subtotal parathyroidectomy for primary chief cell hyperplasia of the multiple endocrine neoplasia type I syndrome. Ann Surg 193:26–29
Katai M, Sakurai A, Ikeo Y et al (2001) Primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1: comparison with sporadic parathyroid adenomas. Horm Metab Res 33:499–503
Gomes EM, Nunes RC, Lacativa PG et al (2007) Ectopic and extranumerary parathyroid glands location in patients with hyperparathyroidism secondary to end stage renal disease. Acta Cir Bras 22:105–109
Schneider R, Waldmann J, Ramaswamy A et al (2011) Frequency of ectopic and supernumerary intrathymic parathyroid glands in patients with renal hyperparathyroidism: analysis of 461 patients undergoing initial parathyroidectomy with bilateral cervical thymectomy. World J Surg 35:1260–1265. doi:10.1007/s00268-011-1079-6
Uno N, Tominaga Y, Matsuoka S et al (2008) Incidence of parathyroid glands located in thymus in patients with renal hyperparathyroidism. World J Surg 32:2516–2519. doi:10.1007/s00268-008-9739-x
Phitayakorn R, McHenry CR (2006) Incidence and location of ectopic abnormal parathyroid glands. Am J Surg 191:418–423
Sofferman RA, Nathan MH (1998) The ectopic parathyroid adenoma: a cost justification for routine preoperative localization with technetium Tc 99 m sestamibi scan. Arch Otolaryngol Head Neck Surg 124:649–654
Fuster D, Ybarra J, Ortin J et al (2006) Role of pre-operative imaging using 99 mTc–MIBI and neck ultrasound in patients with secondary hyperparathyroidism who are candidates for subtotal parathyroidectomy. Eur J Nucl Med Mol Imaging 33:467–473
Perie S, Fessi H, Tassart M et al (2005) Usefulness of combination of high-resolution ultrasonography and dual-phase dual-isotope iodine 123/technetium Tc 99 m sestamibi scintigraphy for the preoperative localization of hyperplastic parathyroid glands in renal hyperparathyroidism. Am J Kidney Dis 45:344–352
Vulpio C, Bossola M, De Gaetano A et al (2010) Usefulness of the combination of ultrasonography and 99mTc-sestamibi scintigraphy in the preoperative evaluation of uremic secondary hyperparathyroidism. Head Neck 32:1226–1235
Acknowledgments
This study was supported in part by (1) the Intramural Program of The Center for Cancer Research, The National Cancer Institute, and (2) the Intramural Division of The National Institute of Diabetes, Digestive and Kidney Diseases, The National Institutes of Health. The authors are grateful to Craig Cochran, R.N. (Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD) for his dedication to the service and patient care.
Conflict of interest
All authors have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nilubol, N., Weinstein, L., Simonds, W.F. et al. Preoperative Localizing Studies for Initial Parathyroidectomy in MEN1 Syndrome: Is There Any Benefit?. World J Surg 36, 1368–1374 (2012). https://doi.org/10.1007/s00268-012-1451-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-012-1451-1